Chemical Compound
(4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-52-[[2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]acetyl]amino]-40-(4-aminobutyl)-49-benzyl-28-[(2S)-butan-2-yl]-31-(3-carbamimidamidopropyl)-34-(carboxymethyl)-16,22-bis(hydroxymethyl)-10,37,43-tris(2-methylpropyl)-19-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carboxylic acid
CAS Registry Number
127869-51-6
Primary record
(4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-52-[[2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]acetyl]amino]-40-(4-aminobutyl)-49-benzyl-28-[(2S)-butan-2-yl]-31-(3-carbamimidamidopropyl)-34-(carboxymethyl)-16,22-bis(hydroxymethyl)-10,37,43-tris(2-methylpropyl)-19-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carboxylic acid
- 库存
- 7,048 克
- 纯度
- 98.1 %
- CAS
- 127869-51-6
化合物标识与属性
- CAS
- 127869-51-6
- PubChem CID
- 16179407
- SMILES
- CC[C@H](C)[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)CC(=O)O)CC(C)C)CCCCN)CC(C)C)CC2=CC=CC=C2)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O)CC(C)C)CO)CCSC)CO
- Canonical SMILES
- CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CN)CSSC[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)CNC1=O
名称与同义词
- Natriuretic peptide, C-type
- Atriopeptin C (pig)
- C-Type natriuretic peptide
- 127869-51-6
- RefChem:164871
- CNP-22
- Natriuretic peptide,C-type
- C Type Natriuretic Peptide
- UNII-3VCD78874L
- CNP (1-22), human
- Natriuretic Peptide, C Type
- Peptide, C-Type Natriuretic
- orb321018
- DTXSID60155686
- 3VCD78874L
- CNP-53
- orb1296718
- C Type Natriuretic Peptide 22
- C Type Natriuretic Peptide 53
- C-Type Natriuretic Peptide-53
- CHEMBL5774357
- DTXCID9078177
- SCHEMBL29360854
- Natriuretic Peptide-22, C-Type
- Natriuretic Peptide-53, C-Type
- Peptide-22, C-Type Natriuretic
- Peptide-53, C-Type Natriuretic
- H-GLSKGCFGLKLDRIGSMSGLGC-OH
- BDBM287915
- PCT-4229-V
- US10087144, Compound CNP
- CNP-22 (Human, Porcine, Rat)
- C-Type Natriuretic Peptide (CNP) (1-22), human
- C93H157N27O28S3
- C-Type Natriuretic Peptide (32-53) (human, porcine, rat)
- AKOS024457659
- BAT-010464
- DA-72416
- FT108409
- RAT C-TYPE NATRIURETIC PEPTIDE(1-22)
- C93-H157-N27-O28-S3
- C-Type natriureticpeptide-22 (swine) (9CI)
- Natriuretic Peptide, C-Type, >=95% (HPLC)
- (4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-52-[[2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]acetyl]amino]-40-(4-aminobutyl)-49-benzyl-28-[(2S)-butan-2-yl]-31-(3-carbamimidamidopropyl)-34-(carboxymethyl)-16,22-bis(hydroxymethyl)-10,37,43-tris(2-methylpropyl)-19-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carboxylic acid
- A1200241
- C-type natriuretic peptide (1-22) (human, rat, swine)
- N0001-012432
- C-Type Natriuretic Peptide (32-53) (human, porcine, rat) acetate salt
- C-Type Natriuretic Peptide-22 (human, porcine, rat) trifluoroacetate salt
- Natriuretic Peptide, C-Type, Human and Porcine - CAS 127869-51-6
- C-Type Natriuretic Peptide (32-53) (human, porcine, rat) trifluoroacetate salt
- (4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-52-((5S,8S,11S)-14-amino-5-(4-aminobutyl)-8-(hydroxymethyl)-11-isobutyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecanamido)-40-(4-aminobutyl)-49-benzyl-28-((S)-sec-butyl)-34-(carboxymethyl)-31-(3-guanidinopropyl)-16,22-bis(hydroxymethyl)-10,37,43-triisobutyl-19-(2-(methylthio)ethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carboxylic acid
- (4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-52-{2-[(2S)-6-AMINO-2-[(2S)-2-[(2S)-2-(2-AMINOACETAMIDO)-4-METHYLPENTANAMIDO]-3-HYDROXYPROPANAMIDO]HEXANAMIDO]ACETAMIDO}-40-(4-AMINOBUTYL)-49-BENZYL-28-[(2S)-BUTAN-2-YL]-31-(3-CARBAMIMIDAMIDOPROPYL)-34-(CARBOXYMETHYL)-16,22-BIS(HYDROXYMETHYL)-10,37,43-TRIS(2-METHYLPROPYL)-19-[2-(METHYLSULFANYL)ETHYL]-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-HEXADECAOXO-1,2-DITHIA-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-HEXADECAAZACYCLOTRIPENTACONTANE-4-CARBOXYLIC ACID
- 1966153-17-2
- CNP
- Glycyl-L-leucyl-L-seryl-L-lysyl-N-{(4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-40-(4-aminobutyl)-49-benzyl-28-[(2S)-butan-2-yl]-31-[3-(carbamimidoylamino)propyl]-4-carboxy-34-(carboxymethyl)-16,22-bis(hydroxymethyl)-10,37,43-tris(2-methylpropyl)-19-[2-(methylsulfanyl)ethyl]-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontan-52-yl}glycinamide
- H-Gly-Leu-Ser-Lys-Gly-Cys(1)-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys(1)-OH
- H-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg -Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH
- H-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH